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In February 1909, thirteen States met in Shanghai for a commission of inquiry into ‘the opium 
question’. These thirteen governments - USA, Austria-Hungary, China, France, Germany, 
United Kingdom, Italy, Japan, Netherlands, Persia, Portugal, Russia and Siam – represented 
not only the major colonial powers of the era, but also the countries that were the major 
consumers and producers of opium.  The report produced by this meeting contained a series of 
recommendations that three years later would form the core obligations of the International 
Opium Convention in 1912, the first multilateral treaty on drug control.  Thus begins the 
international community’s relationship with drug control, a relationship that would evolve over 
time to include numerous additional treaties and to address other types of drugs, including 
cannabis.   
In the United Nations period, the mission to control drugs has resulted in the establishment of 
a major political body – the UN Commission on Narcotic Drugs - the adoption of more than 
one hundred resolutions of the General Assembly and the drafting and ratification of three 
major international conventions.  Yet despite this century old body of international law, and 
the widespread and substantive impact of international drug control treaties on domestic law 
and policy, it has rarely been a focus for legal scholars.  Despite their near universal ratification 
by Member States, discussion of the UN drug treaties is almost completely absent from the 
leading textbooks on public international law.  The number of scholarly monographs on 
international drug control law published over the past fifty years can be counted on the fingers 
of one hand.  
However, in recent years, drug control has begun to emerge as a subject of wider interest, a 
process that has developed alongside, if not being driven by, the increased recognition of the 
global harms that regime has driven. Growing attention to human rights violations and 
environmental damage driven by drug enforcement, as well as moves by a number of countries 
to explore legally regulated markets in recreational cannabis, have increased the interest in drug 
control as an important subject for scrutiny and reform. These developments have raised new 
legal and policy questions, both domestically and internationally, that have challenged Member 
States, scholars and activists to expand their understanding of drug control law, to consider 
how a new international order on drugs might evolve and what it might look like if achieved.  
 
 
Inspired predominantly by policy shifts towards legally regulated cannabis markets in what is 
currently still a small number of jurisdictions, this Special Issue of International Community 
Law Review makes a contribution to this growing body of literature, and to the scholarship on 
these core challenges. The Issue has its origins in ‘Cannabis Regulation and the UN Drug 
Control Treaties’, an Expert Seminar organized by the Transnational Institute (TNI), the Global 
Drug Policy Observatory, Swansea University (GDPO) and the Washington Office on Latin 
America (WOLA), held in Amsterdam 26th - 28th October 2017.  
Despite the fact that international drug control law is over one hundred years old, the core 
objectives and structures have changed little over that time, leading to concerns that the regime 
has not evolved in keeping with modern evidence on drugs, health, crime and related issues. 
‘The Evolution and Modernisation of Treaty Regimes: The Contrasting Cases of International 
Drug Control and Environmental Regulation’ by David Bewley-Taylor and Malgosia 
Fitzmaurice examines this inertia in the context of approaches found within the regime for 
environmental regulation and its underpinning Multilateral Environmental Agreements 
(MEAs). The authors argue that much can be learned from MEAs and their approach the regime 
evolution, particularly in relation to governance structures and the use of Conferences of the 
Parties. 
In ‘Cannabis reform, ‘medical and scientific purposes’ and the Vienna Convention on the Law 
of Treaties’, Rick Lines and Damon Barrett explore the often-contested question of treaty 
interpretation, in particular the suggestion found in some recent literature that a legally 
regulated market in recreational cannabis could be made treaty compliant if labelled as a 
‘scientific experiment’.  Using Articles 31 and 32 of the Vienna Convention, the authors probe 
the shortcomings of this interpretation, arguing that a rigorous approach to questions of 
interpretation is essential in order to advance broader drug policy reforms. 
 
Two of the articles address the potential strategies for pursing domestic drug reform via inter 
se agreements between States using article 41 of the Vienna Convention on the Law of Treaties.  
‘Inter se modification of the UN drug control conventions’ by Martin Jelsma and Neil Boister 
proposes that such an approach would provide a useful safety valve for collective action to 
adjust a treaty regime arguably frozen in time. Inter se modification requires that an agreement 
to derogate from certain cannabis treaty provisions include a clear commitment to the original 
treaty aim to promote the health and welfare of humankind and to the original treaty obligations 
vis-à-vis States not party to the agreement. However, the authors conclude that such a response 
would have benefits when compared against an alternative chaotic scenario of multiple 
unilateral reservations and questionable re-interpretations.  
Continuing on this topic, ‘Regulated legalization of cannabis through positive human rights 
obligations and inter se treaty modification’ by Piet Hein van Kempen and Masha Fedorova 
explores the positive obligations found in human rights law that require States to take measures 
in order to offer the best protection of human rights.  The authors then explore the potential for 
States to use modifications inter se on cannabis to better realise the right to heath under legally 
regulated frameworks.   
It is our hope that these contributions will not only help bring international drug policy to the 
attention of legal scholars and assist in the generation nuanced analysis that reaches beyond its 
 
 
traditional focus, but also be of use to policy makers and practitioners during a time of 
unprecedented flux and challenge.   
